- Home
- SNY vs NWPX Comparison
SNY vs NWPX Comparison
Compare SNY & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- NWPX
- Stock Information
- Founded
- SNY 1994
- NWPX 1966
- Country
- SNY France
- NWPX United States
- Employees
- SNY N/A
- NWPX N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- NWPX Steel/Iron Ore
- Sector
- SNY Health Care
- NWPX Industrials
- Exchange
- SNY Nasdaq
- NWPX Nasdaq
- Market Cap
- SNY 123.6B
- NWPX N/A
- IPO Year
- SNY N/A
- NWPX 1995
- Fundamental
- Price
- SNY $53.63
- NWPX $42.24
- Analyst Decision
- SNY Buy
- NWPX Hold
- Analyst Count
- SNY 2
- NWPX 1
- Target Price
- SNY $62.50
- NWPX $55.00
- AVG Volume (30 Days)
- SNY 3.4M
- NWPX 66.2K
- Earning Date
- SNY 04-24-2025
- NWPX 04-30-2025
- Dividend Yield
- SNY 3.00%
- NWPX N/A
- EPS Growth
- SNY 2.94
- NWPX 62.68
- EPS
- SNY 5.45
- NWPX 3.40
- Revenue
- SNY $48,817,552,946.00
- NWPX $492,548,000.00
- Revenue This Year
- SNY $5.35
- NWPX $2.48
- Revenue Next Year
- SNY $6.69
- NWPX $4.49
- P/E Ratio
- SNY $9.82
- NWPX $12.21
- Revenue Growth
- SNY 7.73
- NWPX 10.85
- 52 Week Low
- SNY $45.80
- NWPX $31.16
- 52 Week High
- SNY $60.12
- NWPX $57.76
- Technical
- Relative Strength Index (RSI)
- SNY 50.20
- NWPX 51.64
- Support Level
- SNY $50.46
- NWPX $39.85
- Resistance Level
- SNY $51.64
- NWPX $43.31
- Average True Range (ATR)
- SNY 1.60
- NWPX 2.02
- MACD
- SNY 0.15
- NWPX 0.23
- Stochastic Oscillator
- SNY 65.92
- NWPX 81.30
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.